Last reviewed · How we verify
Alternative Provision of Medication Abortion Via Advance Provision
This mixed-methods study follows a prospective cohort of participants receiving Mifeprex® (mifepristone) by a clinician in advance of a potential unintended pregnancy. Women participating in this study will be assessed by a clinician and provided Mifeprex® and misoprostol in a clinical setting. To assess acceptability of this service delivery model among participants, and feasibility of implementing a larger randomized controlled trial, the study will survey participants, evaluate any clinical outcomes recorded during clinical visits, and interview participants about their experiences participating in the study.
Details
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | Phase 4 |
| Status | WITHDRAWN |
| Start date | 2020-01 |
| Completion | 2021-01 |
Conditions
- Early Abortion
Interventions
- Mifeprex® (Mifepristone 200 mg)
- Misoprostol 800 mcg
- ella® (ulipristal acetate emergency contraception 30 mg)
- AccuHome® Pregnancy OTC Test
Primary outcomes
- Proportion of participants satisfied with the advance provision model — Participants who do not take Mifeprex® will be surveyed 6 months following study enrollment. Participants who take Mifeprex® at any point during the 6 month study period will be surveyed one week after taking Mifeprex®.
Proportion of participants who report being "somewhat satisfied" or "very satisfied" when asked "How satisfied are you with the advance provision model?" - Proportion of participants who are confident that they could use the abortion pills correctly if they got pregnant and decided to have an abortion using the advance provision model — Participants who do not take Mifeprex® will be surveyed 6 months following study enrollment. Participants who take Mifeprex® at any point during the 6 month study period will be surveyed one week after taking Mifeprex®.
Proportion of participants who report "somewhat confident" or "completely confident" when asked "If you got pregnant and wanted an abortion in the next few months, how confident do you feel that you could use the abortion pills correctly?" - Proportion of participants who would recommend the advance provision model to a friend — Participants who do not take Mifeprex® will be surveyed 6 months following study enrollment. Participants who take Mifeprex® at any point during the 6 month study period will be surveyed one week after taking Mifeprex®.
Proportion of participants who report "probably yes" or "definitely yes" when asked "Would you recommend getting the abortion pills in advance instead of going to a clinic to a friend?"